Lymphocyte cytotoxicity for autologous hepatocytes.

Por Mondelli, M, Eddleston, A L
Publicado em 1984

Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.

Por Scarselli, E, Cerino, A, Esposito, G, Silini, E, Mondelli, M U, Traboni, C
Publicado em 1995

Comparative evaluation of two serologic typing methods for hepatitis C virus.

Por Cerino, A, Cividini, A, Asti, M, Lanza, A, Silini, E, Mondelli, M U
Publicado em 1996

Virological features of hepatitis C virus infection in hemodialysis patients.

Por Silini, E, Bono, F, Cerino, A, Piazza, V, Solcia, E, Mondelli, M U
Publicado em 1993

Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency.

Por Mondelli, M, Mieli-Vergani, G, Eddleston, A L, Williams, R, Mowat, A P
Publicado em 1984

In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.

Por Mondelli, M, Alberti, A, Tremolada, F, Williams, R, Eddleston, A L, Realdi, G
Publicado em 1986

Natural killer activity in patients with acute viral hepatitis.

Por Chemello, L, Mondelli, M, Bortolotti, F, Schiavon, E, Pontisso, P, Alberti, A, Rondanelli, E G, Realdi, G
Publicado em 1986

Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody.

Por Mondelli, M U, Cerino, A, Boender, P, Oudshoorn, P, Middeldorp, J, Fipaldini, C, La Monica, N, Habets, W
Publicado em 1994

Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection.

Por Mondelli, M U, Bortolotti, F, Pontisso, P, Rondanelli, E G, Williams, R, Realdi, G, Alberti, A, Eddleston, A L
Publicado em 1987

Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Por Alexander, G J, Mondelli, M, Naumov, N V, Nouriaria, K T, Vergani, D, Lowe, D, Eddleston, A L, Williams, R
Publicado em 1986

Hepatitis C virus (HCV) core serotypes in chronic HCV infection.

Por Mondelli, M U, Cerino, A, Bono, F, Cividini, A, Maccabruni, A, Aricò, M, Malfitano, A, Barbarini, G, Piazza, V, Minoli, L
Publicado em 1994

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.

Por Puntoriero, G, Meola, A, Lahm, A, Zucchelli, S, Ercole, B B, Tafi, R, Pezzanera, M, Mondelli, M U, Cortese, R, Tramontano, A, Galfre', G, Nicosia, A
Publicado em 1998

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial

Por Colombatto, P, Brunetto, M R, Maina, A M, Romagnoli, V, Almasio, P, Rumi, M G, Ascione, A, Pinzello, G, Mondelli, M, Muratori, L, Rappuoli, R, Rosa, D, Houghton, M, Abrignani, S, Bonino, F
Publicado em 2014

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

Por Spada, E, Mele, A, Berton, A, Ruggeri, L, Ferrigno, L, Garbuglia, A R, Perrone, M P, Girelli, G, Del Porto, P, Piccolella, E, Mondelli, M U, Amoroso, P, Cortese, R, Nicosia, A, Vitelli, A, Folgori, A
Publicado em 2004